Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.03
Schlusskurs vom Vortag:
$0.03
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$1.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.96M
KGV:
0.00
EPS:
-0.7492
Netto-Cashflow:
$-19.63M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$1.42
Iterum Therapeutics Plc Stock (ITRM) Company Profile
Firmenname
Iterum Therapeutics Plc
Sektor
Branche
Telefon
(872) 225-6077
Adresse
3 DUBLIN LANDINGS, DUBLIN 1
Compare ITRM vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.00 | 1.60M | 0 | -26.96M | -19.63M | -0.7492 |
VRTX
Vertex Pharmaceuticals Inc
|
436.83 | 111.05B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
742.73 | 79.01B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
793.73 | 50.08B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
310.76 | 41.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
309.88 | 34.67B | 5.36B | 287.73M | 924.18M | 2.5229 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-28 | Hochstufung | Gabelli & Co | Sell → Hold |
| 2021-03-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | Herabstufung | Gabelli & Co | Buy → Sell |
| 2019-12-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten
Iterum Therapeutics plc (ITRMF) Competitors - Meyka
Why Is Iterum Therapeutics plc (ITRMF) Stock Down Today? - Meyka
Why Is Iterum Therapeutics plc (ITRMF) Stock Up Today? - Meyka
What's going on with Iterum Therapeutics stock Monday? - MSN
Retail Surge: Does Iterum Therapeutics plc outperform in volatile markets2026 Momentum & Comprehensive Market Scan Reports - baoquankhu1.vn
Dividend HistoryIterum Therapeutics (ITRMF) - Zacks Investment Research
Published on: 2026-04-10 21:42:25 - baoquankhu1.vn
Breakout Zone: What are the future prospects of Iterum Therapeutics plc2026 Macro Impact & Weekly Market Pulse Updates - baoquankhu1.vn
ITRMF (Iterum Therapeutics) Dividend Payout Ratio : 0.00 (As of Sep. 2025) - GuruFocus
Iterum Therapeutics plc (ITRMF) stock price, news, quote and history - Yahoo Finance Australia
Iterum Therapeutics plc (ITRMF) Dividend News Alerts - DividendInvestor.com
Iterum Therapeutics plc (ITRMF) insider ownership and holdings - Yahoo Finance Singapore
ITRMF (Iterum Therapeutics) Marketable Securities : $0.00 Mil (As of Sep. 2025) - GuruFocus
EBITDA of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Cost of goods sold of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Operating expenses (excl. COGS) of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Gross profit of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Pretax income of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Total revenue of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Non-controlling/minority interest of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
EBIT of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Dilution adjustment of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Non-operating income (total) of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Operating income of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Discontinued operations of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Taxes of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Diluted net income available to common stockholders of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
ITRM Iterum Therapeutics plc NASDAQ Q4 2025 results 03 Apr 2026: Earnings drivers and outlook - Meyka
Cash from investing activities of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Cash from operating activities of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Free cash flow of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Iterum Therapeutics plc Cash Flow – OTC:ITRMF - TradingView
Iterum Therapeutics plc Earnings and Revenue – OTC:ITRMF - TradingView
Iterum Therapeutics (ITRMF) Dividend Yield (TTM) - Zacks Investment Research
ITERUM THERAPEUTICS WACC %: 8.11% — 17% Below Median - GuruFocus
Total liabilities of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Total liabilities & shareholders' equities of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Net debt of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Iterum Therapeutics PLC (ITRMF) Stock Price & 30 Year Financial Data - GuruFocus
Iterum Therapeutics plc Balance Sheet – OTC:ITRMF - TradingView — Track All Markets
Iterum Therapeutics PLC (ITRMF) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Iterum Therapeutics PLC (ITRMF)Valuation Measures & Financial Statistics - GuruFocus
EBITDA per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Enterprise value to EBITDA ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Operating cash flow per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
EBIT per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Working capital per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
EBITDA margin % of Iterum Therapeutics plc – OTC:ITRMF - TradingView — Track All Markets
Long term debt to total equity ratio of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Free cash flow per share of Iterum Therapeutics plc – OTC:ITRMF - TradingView
Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):